Does levodopa alter depression and psychopathology in Parkinsonism patients?
Open Access
- 1 December 1973
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 36 (6) , 925-935
- https://doi.org/10.1136/jnnp.36.6.925
Abstract
Twenty-seven Parkinsonism patients and 31 controls, matched for age and verbal IQ, were tested on an objectively scored personality test (Minnesota Multiphasic Personality Inventory) at the beginning of the patients' levodopa therapy and three months later. Patients, but not the controls, were retested after 15 months of levodopa treatment. The patients, all of whom were intact intellectually, obtained MMPI scores indicating moderate depression before beginning levodopa treatment. There was no test evidence to indicate that levodopa significantly increased or decreased the amount of depression in the patients after three or 15 months of levodopa. The patient group, however, significantly increased their Index of Psychopathology (Ip) score after 15 months of levodopa but not after three months.Keywords
This publication has 31 references indexed in Scilit:
- Psychiatric aspects in Parkinsonism treated with L-dopaJournal of Neurology, Neurosurgery & Psychiatry, 1971
- L-DOPA, PARKINSONISM, AND DEPRESSIONThe Lancet, 1970
- EFFECTS OF L-DOPA IN PATIENTS WITH DEMENTIAThe Lancet, 1970
- Treatment of Parkinsonism with Laevo-DopaBMJ, 1970
- DEPRESSION DURING L-DOPA TREATMENTThe Lancet, 1969
- L-DOPA IN POSTENCEPHALITIC PARKINSONISMThe Lancet, 1969
- Depressive symptoms in Parkinson patients referred for thalamotomy.Journal of Neurology, Neurosurgery & Psychiatry, 1967
- Changes in MMPI Scale Scores and an Index of Psychopathology following Unilateral Temporal Lobectomy for EpilepsyEpilepsia, 1965
- Another look at MMPI profile types in multiple sclerosis.Journal of Consulting Psychology, 1961
- Parkinson's diseaseJournal of Chronic Diseases, 1958